Curexo큐렉소
060280 · KOSDAQ · ₩060280 · 큐렉소
₩7,310▲ ₩50 (0.69%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩75B | ₩56B | ₩73B | ₩65B | ₩43B |
| Cost of sales | ₩50B | ₩41B | ₩54B | ₩51B | ₩34B |
| Gross profit | ₩25B | ₩15B | ₩19B | ₩14B | ₩9.1B |
| Operating income | ₩2.4B | −₩5.8B | ₩1.1B | ₩1.1B | −₩1.8B |
| Net income | ₩2.8B | −₩8.8B | −₩4.9B | −₩3B | −₩2.3B |
| Net income to shareholders | ₩2.8B | −₩8.8B | −₩4.9B | −₩3B | −₩2.3B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩101B | ₩103B | ₩107B | ₩98B | ₩61B |
| Current assets | ₩87B | ₩88B | ₩91B | ₩76B | ₩50B |
| Cash and equivalents | ₩19B | ₩14B | ₩17B | ₩1.6B | ₩2.6B |
| Total liabilities | ₩4.9B | ₩9.2B | ₩6.9B | ₩17B | ₩18B |
| Current liabilities | ₩4.2B | ₩7.9B | ₩4.9B | ₩17B | ₩18B |
| Borrowings | — | ₩0 | ₩0 | ₩6.7B | ₩5.3B |
| Total equity | ₩96B | ₩93B | ₩100B | ₩82B | ₩43B |
| Shareholders' equity | ₩96B | ₩93B | ₩100B | ₩82B | ₩43B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩11B | ₩3.8B | ₩5.1B | −₩13B | −₩8.7B |
| Capital spending | ₩2.5B | ₩3.4B | ₩2.2B | ₩361M | ₩592M |
| Free cash flow | −₩14B | ₩465M | ₩2.9B | −₩13B | −₩9.3B |
Consolidated where available. Amounts in won.
Also known as: Curexo / 큐렉소 / 060280 / KRX:060280
Source: KRX statistical information